Statistics
Publications
2
Citations
40
H-Index
2
Active since
2017
Affiliations
Mika Sato-Nakai is an author at Roche (United States) specializing in anaplastic lymphoma kinase inhibitors, cancer metabolism, and pharmacology.
Publications per year
2017–2017
2
2
Metabolites of alectinib in human: their identification and pharmacological activity
Mika Sato-Nakai, Kosuke Kawashima, Toshito Nakagawa et al. · Heliyon · 2017 · 20 citations · Full text
1–2 of 2